Protein Kinase R Is Increased and Is Functional in Hepatitis C Virus-Related Hepatocellular Carcinoma

American Journal of Gastroenterology

Volumn 98, Issue 11, 2003, Pages 2528-2534

  Hiasa, Yoichi ^b   Kamegaya, Yoshitaka ^b   Nuriya, Hideko ^b   Onji, Morikazu ^b   Kohara, Michinori ^b   Schmidt, Emmett V ^b   Chung, Raymond T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INITIATION FACTOR; INITIATION FACTOR 2ALPHA; PROTEIN INHIBITOR; PROTEIN KINASE; PROTEIN KINASE R; PROTEIN P58; RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL MATURATION; CELL PROLIFERATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; ENZYME INHIBITION; EUKARYOTE EVOLUTION; GROWTH INHIBITION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER HISTOLOGY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE SECTION; TUMOR SUPPRESSOR GENE; VIRUS CARCINOGENESIS; VIRUS TRANSCRIPTION; WESTERN BLOTTING;

EID: 0344496152     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(03)01696-4     Document Type: Article

References (35)

1. Alter MJH. Epidemiology of hepatitis C. Hepatology 1997;26:62-5.
2. Okuda K. Hepatitis C and hepatocellular carcinoma. J Gastroenterol Hepatol 1998;13:294-8.
3. Clemens MJ, Elia A. The double-stranded RNA-dependent protein kinase PKR: Structure and function. J Interferon Cytokine Res 1997;17:503-24.
4. Taylor DR, Lee SB, Romano PR, et al. Autophosphorylation sites participate in the activation of the double-stranded-RNA-activated protein kinase PKR. Mol Cell Biol 1996;16:6295-302.
5. Merrick WC, Hershey JWB. The pathway and mechanism of eukaryotic protein synthesis. In: Hershey J, Mathews M, Sonenberg N, eds. Transcriptional control. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1996:31-70.
6. O'Malley RP, Mariano TM, Siekierka J, et al. A mechanism for the control of protein synthesis by adenovirus VA RNAI. Cell 1986;44:391-400.
7. Soderlund H, Pettersson U, Vennstrom B, et al. A new species of virus-coded low molecular weight RNA from cells infected with adenovirus type 2. Cell 1976;7:585-93.
8. Chang H-W, Watson JC, Jacobs BL. The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. Proc Natl Acad Sci USA 1992;89:4825-9.
9. Watson JC, Chang H-W, Jacobs BL. Characterization of a vaccinia virus-encoded double-stranded RNA-binding protein that may be involved in inhibition of the double-stranded RNA-dependent protein kinase. Virology 1991;185:206-16.
10. Carroll K, Elroy-Stein O, Moss R, et al. Recombinant vaccinia virus K3L gene product prevents activation of double-stranded RNA-dependent, initiation factor 2 alpha-specific protein kinase. J Biol Chem 1993;268:12837-42.
11. IPK and vaccinia virus K3L is mediated by unique domains. Mol Cell Biol 1996;16:4172-81.
12. r 68,000 from influenza virus-infected cells. Proc Natl Acad Sci USA 1990;87:6208-12.
13. Lee TG, Tomita J, Hovanessian AG, et al. Characterization and regulation of the 58,000-dalton cellular inhibitor of the interferon-induced protein kinase. J Biol Chem 1992;267:14238-43.
14. Barber GN, Thompson S, Lee TG, et al. The 58-kilodalton inhibitor of the interferon-induced double-stranded RNA-activated protein kinase is a tetratricopeptide repeat protein with oncogenic properties. Proc Natl Acad Sci USA 1994;91:4278-82.
15. Gale M Jr, Korth MJ, Tang NM, et al. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 1997;230:217-27.
16. Gale M Jr, Blakely CM, Kwieciszewski B, et al. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: Molecular mechanisms of kinase regulation. Mol Cell Biol 1998;18:5208-18.
17. He Y, Tan S-L, Tareen SU, et al. Regulation of mRNA translation and cellular signaling by hepatitis C virus nonstructural protein NS5A. J Virol 2001;75:5090-8.
18. Taylor DR, Shi ST, Romano PR, et al. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science 1999;285:107-10.
19. Francois C, Duverlie G, Rebouillat D, et al. Expression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesis. J Virol 2000;74:5587-96.
20. Proud CG. PKR: A new name and new roles. Trends Biochem Sci 1995;20:241-6.
21. Williams BRG. The role of the dsRNA-activated kinase, PKR, in signal transduction. Semin Virol 1995;6:191-202.
22. Barber GN, Wambach M, Thompson S, et al. Mutants of the RNA-dependent protein kinase (PKR) lacking double-stranded RNA binding domain I can act as transdominant inhibitors and induce malignant transformation. Mol Cell Biol 1995;15:3138-46.
23. Donze O, Jagus R, Koromilas AE, et al. Abrogation of translation initiation factor eIF-2 phosphorylation causes malignant transformation of NIH 3T3 cells. EMBO J 1995;14:3828-34.
24. Koromilas AE, Roy S, Barber GN, et al. Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. Science 1992;257:1685-9.
25. Meurs EF, Galabru J, Barber GN, et al. Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Proc Natl Acad Sci USA 1993;90:232-6.
26. Gale M Jr, Kwieciszewski B, Dossett M, et al. Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase. J Virol 1999;73:6506-16.
27. Goh KC, deVeer MJ, Williams BR. The protein kinase PKR is required for p38 MAPK activation and the innate immune response to bacterial endotoxin. EMBO J 2000;19:4292-7.
28. Deb A, Haque SJ, Mogensen T, et al. RNA-dependent protein kinase PKR is required for activation of NF-κB by IFN-γ in a STAT1-independent pathway. J Immunol 2001;166:6170-80.
29. Sato M, Nakamura M, Saitoh H, et al. Tumor necrosis factor-α -converting enzyme and tumor necrosis factor-α in human dilated cardiomyopathy. Circulation 1999;99:3260-5.
30. Meurs E, Chong K, Galabru J, et al. Molecular cloning and characterization of the human double stranded RNA-activated protein kinase induced by interferon. Cell 1990;62:379-90.
31. Haase AT, Retzel EF, Staskus KA. Amplification and detection of lentiviral DNA inside cells. Proc Natl Acad Sci USA 1990;87:4971-5.
32. Nuovo GJ, MacConnell P, Forde A, et al. Detection of human papillomavirus DNA in formalin-fixed tissues by in situ hybridization after amplication by polymerase chain reaction. Am J Pathol 1991;139:847-54.
33. Delhem N, Sabile A, Gajardo R, et al. Activation of the interferon-inducible protein kinase PKR by hepatocellular carcinoma derived-hepatitis C virus core protein. Oncogene 2001;20:5836-45.
34. Shimada A, Shiota G, Miyata H, et al. Aberrent expression of double-stranded RNA-dependent protein kinase in hepatocytes of chronic hepatitis and differentiated hepatocellular carcinoma. Cancer Res 1998;58:4434-8.
35. Kim SH, Forman AP, Mathews MB, et al. Human breast cancer cells contain elevated levels and activity of the protein kinase, PKR. Oncogene 2000;19:3086-94.